TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GlaxoSmithKline Pharma A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
63,663
|
59,207
|
59,959 |
Earnings before taxes |
2,075
|
1,929
|
1,924 |
Total assets |
15,742
|
15,573
|
18,489 |
Current assets |
15,422
|
15,203
|
17,870 |
Current liabilities |
10,658
|
10,576
|
13,720 |
Equity capital |
5,084
|
4,968
|
4,677 |
- share capital |
1,342
|
1,345
![]() |
1,345 |
Employees (average) |
75
![]() |
75
![]() |
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.3%
|
31.9%
|
25.3% |
Turnover per employee |
849
|
789
|
799 |
Profit as a percentage of turnover |
3.3%
![]() |
3.3%
|
3.2% |
Return on assets (ROA) | |||
Current ratio |
144.7%
|
143.8%
|
130.2% |
Return on equity (ROE) |
40.8%
|
38.8%
|
41.1% |
Change turnover |
4,588
|
-752
|
561 |
Change turnover % |
8%
|
-1%
|
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.